Yayın:
A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non‐Small Cell Lung Cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEdanur Topalan
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorAhmet Büyükgüngör
dc.contributor.authorMelih Çiğdem
dc.contributor.authorS Futóné Gura
dc.contributor.authorBelgin Sever
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorHasan DeMi̇rci̇
dc.contributor.authorHalil I. Ciftci
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.contributor.orcid0000-0002-9135-5397
dc.contributor.orcid0000-0002-9796-7669
dc.date.accessioned2025-11-13T10:30:13Z
dc.date.issued2025-04-01
dc.identifier.doihttps://doi.org/10.1002/ardp.202400992
dc.identifier.endpagee2400992
dc.identifier.issn0365-6233
dc.identifier.issue4
dc.identifier.openalexW4409229119
dc.identifier.startpagee2400992
dc.identifier.urihttps://hdl.handle.net/11421/4354
dc.identifier.urihttps://doi.org/10.1002/ardp.202400992
dc.identifier.volume358
dc.language.isoen
dc.relation.ispartofArchiv der Pharmazie
dc.rightsopenAccess
dc.subjectGefitinib
dc.subjectErlotinib
dc.subjectOsimertinib
dc.subjectEpidermal growth factor receptor
dc.subjectEGFR inhibitors
dc.subjectCancer research
dc.subjectAfatinib
dc.subjectNeratinib
dc.subjectT790M
dc.subjectERBB3
dc.subjectLung cancer
dc.subjectMedicine
dc.subjectErbB
dc.subjectTyrosine kinase
dc.subjectERBB4
dc.subjectReceptor tyrosine kinase
dc.subjectCancer
dc.subjectOncology
dc.subjectTrastuzumab
dc.subjectReceptor
dc.subjectInternal medicine
dc.subjectBreast cancer
dc.subject.sdg3
dc.titleA Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non‐Small Cell Lung Cancer
dc.typereview
dspace.entity.typePublication
local.authorid.openalexA5040352588

Dosyalar

Koleksiyonlar

Publications